(Q50801877)

English

Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria.

scientific article published in October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

liver transplantation

1 reference

based on heuristic

inferred from title

author name string

Ting Gao

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Qiang Xia

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

De Kai Qiu

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Yi Yan Feng

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Jia Chang Chi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Si Yue Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Zhi Feng Xi

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Jian Jun Zhang

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Ning Xu

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Shi Yao Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Yu Lan Qiu

11

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Li Wei Shen

12

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Ting Ting Zhou

13

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Xiao Jun Dong

14

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Qi Gen Li

15

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Hai Li

16

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

publication date

1 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Journal of Digestive Diseases

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

14

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

552-558

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

The role of entecavir in preventing hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

The new liver allocation system: moving toward evidence-based transplantation policy

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Current controversies surrounding liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Resection and liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for HCC: its role: Eastern and Western perspectives

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12083

21 January 2018

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/TP.0B013E31816B67E4

Identifiers

10.1111/1751-2980.12083

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23782458

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50801877&oldid=2045154938"